Labocanna

Labocanna P/B

The P/B (Price-to-Book Ratio) of Labocanna (LCN.WA) as of Oct 18, 2026 is 0.81. In the previous year, P/B (Price-to-Book Ratio) was 0.70 — a change of 15.29% (higher).

P/B

0.81

YoY

15.29%

Last updated:

P/B (Price-to-Book Ratio) of Labocanna is 2025 0.81 . P/B (Price-to-Book Ratio) of Labocanna was 2024 0.70 . It decreases by 15.29% higher compared to the previous year.

The Labocanna P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2018
9.79 PLN
Jan 1, 2019
41.82 PLN
Jan 1, 2020
32.86 PLN
Jan 1, 2021
0.52 PLN
Jan 1, 2022
0.60 PLN
Jan 1, 2023
0.66 PLN
Jan 1, 2024
0.70 PLN
Jan 1, 2025
0.81 PLN
The Labocanna P/B history
YEARP/BYoY
0.81+15.29%
0.70+6.73%
0.66+8.54%
0.60+15.54%
0.52-98.41%
32.86-21.43%
41.82+327.27%
9.79+225.53%
3.01+77.78%
1.69+36.40%
1.24—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Labocanna Stock analysis

What does Labocanna do? Labocanna SA is a pharmaceutical company based in Koszalin, Poland, operating within the Health Care sector. The company's primary focus is on the hemp business, as indicated by its operational description. It completed its initial public offering (IPO) on July 4, 2011, marking its entry into the public market. Labocanna SA is listed under the ticker symbol LCN.WA and holds the ISIN code PLCCTLS00017. The company's headquarters are located in Koszalin, a city in the West Pomeranian Voivodeship (Woj. Zachodniopomorskie) of Poland. Its official website is https://labocanna.pl/, which serves as a primary source of information about its operations and offerings. The company operates within the pharmaceutical industry, though specific details about its products, services, or market position are not provided in the available information. Labocanna SA's activities are centered around the hemp sector, which may include the development, production, or distribution of hemp-related products, though the exact nature of these activities remains unspecified. The company's public listing and headquarters location are key identifiers for its operational and financial profile. No additional details regarding founding year, key personnel, acquisitions, or financial figures are included in the provided data. Labocanna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Labocanna stock

P/B (Price-to-Book Ratio) of Labocanna is 0.81 in 2025.

P/B (Price-to-Book Ratio) of Labocanna changed from 0.70 to 0.81, representing a 15.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Labocanna since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Labocanna with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Labocanna

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Labocanna